富马酸泰诺福韦酯; CAS 202138-50-9

富马酸泰诺福韦酯; CAS 202138-50-9 中文名称：富马酸泰诺福韦二吡呋酯  英文名称：Tenofovir disoproxil fumarate  英文别名：2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, 1,9-bis(1-methylethyl) ester, 5-oxide, (2E)-2-butenedioate;Tenofovir DF  Cas 号：202138-50-9 含量标准：99% HPLC 富马酸泰诺福韦酯中间体; CAS 147127-20-6  中文名称：泰诺福韦; (R)-9-(2-磷酸甲氧基丙基)-腺嘌呤  英文名称：Tenofovir  英文别名：1-(6-Aminopurin-9-yl)propan-2-yloxymethylphosphonic acid  Cas 号： 147127-20-6  含量标准：98% HPLC 富马酸泰诺福韦酯中间体;CAS 14047-28-0 中文名称：(R)-9-(2-羟基丙基)腺嘌呤  英文名称：(R)-9-(2-Hydroxypropyl)adenine  英文别名：9-[(2R)-2-Hydroxypropyl]adenine; D-(-)-9-(2-Hydroxypropyl)adenine; (R)-6-amino-alpha-methyl-9H-Purine-9-ethanol  Cas 号：14047-28-0  含量标准：98% HPLC

We are offering three key services for new drug application, a. Mature(repeatable) pilot process with independent intellectual property rights; b. High purity sample designed for pharm companies; c. Impurity study. Our main products are Ulipristal acetate intermediates &impurities; Alogliptin benzoate intermediates, impurities &metabolin; Ezetimibe intermediates &impurities; Abiraterone Acetate; Dienogest; Tenofovir disoproxil fumarate & its intermediates; Bortezomib; Cabazitaxel; Lacosamide intermediates; Minodronic acid.